BioSpace News Archive

Masimo announced that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measurements: noninvasive, continuous hemoglobin and pleth variability index.

CVS Health Corporation announced operating results for the three months ended June 30, 2019.

NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, reports financial results for the three and six months ended June 30, 2019 and provides a business update.

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced positive results from the Phase III PROfound trial of LYNPARZA 300 mg twice daily in men with metastatic castration-resistant prostate cancer who have a *homologous recombination repair gene mutation and have failed prior treatment with new hormonal anticancer agents.

ScottCare Cardiovascular Solutions and the EP Heart Cardiovascular Electrophysiology Training Program at The University of Texas Health Science Center at Houston (UTHealth) today announced a collaboration intended to provide an intensive training experience for individuals interested in pursuing a career as Cardiac Implantable Electronic Device Specialists and Technical Specialists.

Recognized industry leader to head clinical development programs

Conference call scheduled today at 9:00 a.m. ET

Reliv International, a 30-year-old wellness company located in Chesterfield, MO, announced today that Dr. Alfredo Galvez has been appointed as the company’s Chief Scientific Advisor

Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today reported financial results for the second quarter ended June 30, 2019.

Tivity Health, Inc. (NASDAQ:TVTY) today announced financial results for the second quarter ended June 30, 2019.